Send to

Choose Destination
J Pharm Sci. 2008 Dec;97(12):5080-3. doi: 10.1002/jps.21364.

PATH's approach to product introduction in developing countries.

Author information

PATH, Technology Solutions, Program Officer, 1455 NW Leary Way, Seattle, Washington 98107, USA.


Health interventions developed for wealthy nations are difficult to introduce in developing countries due to a lack of sufficient technological, financial, political, or infrastructural resources. Increasingly, however, product developers are creating new technologies that meet the needs of low-resource settings. Experience has shown that many activities must be undertaken to prepare health systems to accept and embrace new, improved, or under-utilized health technologies. This article describes three health technologies--a diagnostic test for vitamin A deficiency, new cervical cancer vaccines, and the vaccine vial monitor--that PATH, a global health organization, has helped advance for developing-country markets.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center